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Abstract-Ca
2ϩ transients measured in failing human ventricular myocytes exhibit reduced amplitude, slowed relaxation, and blunted frequency dependence. In the companion article (O'Rourke B, Kass DA, Tomaselli GF, Kääb S, Tunin R, Marbán E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart, I: experimental studies. Circ Res. 1999;84:562-570), O'Rourke et al show that Ca 2ϩ transients recorded in myocytes isolated from canine hearts subjected to the tachycardia pacing protocol exhibit similar responses. Analyses of protein levels in these failing hearts reveal that both SR Ca 2ϩ ATPase and phospholamban are decreased on average by 28% and that Na ϩ /Ca 2ϩ exchanger (NCX) protein is increased on average by 104%. In this article, we present a model of the canine midmyocardial ventricular action potential and Ca 2ϩ transient. The model is used to estimate the degree of functional upregulation and downregulation of NCX and SR Ca 2ϩ ATPase in heart failure using data obtained from 2 different experimental protocols. Model estimates of average SR Ca 2ϩ ATPase functional downregulation obtained using these experimental protocols are 49% and 62%. Model estimates of average NCX functional upregulation range are 38% and 75%. Simulation of voltage-clamp Ca 2ϩ transients indicates that such changes are sufficient to account for the reduced amplitude, altered shape, and slowed relaxation of Ca 2ϩ transients in the failing canine heart. Model analyses also suggest that altered expression of Ca Key Words: excitation-contraction coupling Ⅲ heart failure Ⅲ midmyocardial ventricular action potential Ⅲ Ca 2ϩ transient R ecent studies using the canine tachycardia pacinginduced model of heart failure [1] [2] [3] [4] [5] [6] [7] [8] demonstrate that changes in cellular electrophysiological and excitationcontraction (E-C) coupling processes are qualitatively similar to those observed in cells isolated from failing human heart. In human heart failure, I K1 current density measured at hyperpolarized membrane potentials is reduced by Ϸ50%, 9, 10 and density of the transient outward current I to1 is reduced by Ϸ75% in subepicardial 11 and Ϸ40% in midmyocardial ventricular cells 9 and is unchanged in subendocardial ventricular cells. 11 The magnitude of I K1 is reduced by Ϸ40%, and that of I to1 by Ϸ70% in failing canine midmyocardial cells. 5 Expression of proteins involved in E-C coupling is also altered in human heart failure. Sarcoplasmic reticulum (SR) Ca 2ϩ ATPase mRNA level, [12] [13] [14] [15] [16] protein level, 12, 17, 18 and uptake rate 19 are reduced by Ϸ50% in end-stage heart failure. Na ϩ /Ca 2ϩ exchanger (NCX) mRNA levels are increased by Ϸ55% to 79%, 12, 20 and NCX protein levels increase 36% to 160%. 12,20 -22 Less information is available with regard to NCX function in heart failure. However, Reinecke et al 22 reported an 89% increase in sodium-gradient-stimulated 45 
Ca
2ϩ uptake in human heart sarcolemmal vesicles.
As described in the preceding article by O'Rourke et al, 23 alterations of intracellular Ca 2ϩ handling in failing canine midmyocardial ventricular myocytes parallel those observed in human. In particular, the time constant of Ca 2ϩ uptake in the absence of Na ϩ /Ca 2ϩ exchange is prolonged in failing cells (576Ϯ83 versus 282Ϯ30 ms in controls), suggesting a functional downregulation of the SERCA2a. This observation is consistent with Western blot analyses indicating that SR Ca 2ϩ ATPase protein levels are reduced in failing heart by 28%. Additionally, in the presence of cyclopiazonic acid (CPA, a blocker of the SR Ca 2ϩ ATPase pump), the time constant of Ca 2ϩ extrusion is larger in normal than failing cells (813Ϯ269 versus 599Ϯ48 ms). This observation is consistent with Western blot analyses indicating a 104% increase in the level of expression of the NCX in failing cells. Taken together, these results suggest that SR Ca 2ϩ uptake is impaired and that Ca 2ϩ extrusion via the NCX is enhanced in myocytes isolated from the failing canine heart in a way that is similar qualitatively to that seen in human patients.
In this article, we use the data of O'Rourke et al 23 to develop a computational model of the action potential and of intracellular Ca 2ϩ handling in normal and failing canine ventricular myocytes using biophysically detailed descriptions of both sarcolemmal currents and key components of E-C coupling. With the limits of individual alterations fixed using experimentally derived values, the model is used to quantify the extent to which each parameter (I to1 , I K1 , SR Ca 2ϩ ATPase, and NCX) contributes to the overall change in electrical and Ca 2ϩ dynamics in heart failure. The results support the hypothesis that differences in expression of sarcolemmal ion channels and Ca 2ϩ handling proteins measured experimentally are sufficient to account for the altered action potential waveform and Ca 2ϩ transient of the failing canine cardiomyocyte.
Materials and Methods

Normal Canine Ventricular Cell Model
Jafri et al 24 have presented a model of Ca 2ϩ handling in the guinea pig ventricular myocyte that incorporates the following: (1) sarcolemmal ion currents of the Luo-Rudy phase II ventricular cell model, 25 (2) a state model of the L-type Ca 2ϩ current in which Ca 2ϩ -mediated inactivation occurs via the mechanism of mode switching, 26 (3) calcium-induced calcium release from SR via ryanodine-sensitive calcium release (RyR) channels using a model adapted from that of Keizer and Levine, 27 and (4) a restricted subspace located between the junctional SR (JSR) and T tubules into which both L-type Ca 2ϩ and RyR channels empty. The model of the canine midmyocardial ventricular cell used in this study is derived from this guinea pig ventricular cell model. All dynamic equations, parameters, and initial conditions for this new model are given in the Appendix. The following modifications to the model of Jafri et al 24 have been made to better represent properties of canine midmyocardial ventricular cells.
I to1
Canine epicardial and midmyocardial ventricular cell action potentials exhibit a prominent notch in phase 1 of the action potential that results from the presence of 2 transient outward currents: a Ca 2ϩ -independent 4-aminopyridine (4-AP)-sensitive current (I to1 ) 5, 28, 29 and a Ca 2ϩ -dependent current (I to2 ). 29, 30 The Ca 2ϩ -independent component I to1 is modeled on the basis of the formulation of Campbell et al 31 for ferret ventricular cells. Peak I to1 conductance (G to1 ) was adjusted to yield a linear plot of peak current density in response to 500-ms-duration voltage-clamp stimuli from a holding potential of -80 mV, with slope 0.3 pA/pF-mV and y-intercept 4.6 pA/pF. This agrees well with experimental measurements reported for canine I to1 at 37°C by Liu et al 28 (see their Figure10B: slope, 0.28 pA/pF-mV, and y-intercept, 5 pA/pF). Activation rate constants were scaled to yield a time to peak of Ϸ8 ms at a clamp potential of ϩ10 mV (see Figure 5B of Tseng and Hoffman). 29 Inactivation rate constants were adjusted to yield a decay time constant of Ϸ20 ms. 29 The Ca 2ϩ -dependent chloride (Cl-) current I to2 was not incorporated in this model.
I Kr
The delayed rectifier current I K in both canine and guinea pig ventricular myocytes consists of rapid-and slow-activating components known as I Kr and I Ks , respectively. Models of I Kr and I Ks in guinea pig ventricular cells have been developed. 32 Figure 11 ). The time constant of activation at ϩ5 mV was set to 100 ms, 33 and the time constant of deactivation at -60 mV was set to 3000 ms, 34 thereby constraining the rate constants K 12 (V) and K 21 (V). A fixed increment of 27 ms was added to Equation 2 to bound the time constant away from 0 at depolarized potentials. The maximum conductance G Kr was adjusted to yield a tail current density of 0.2 pA/pF in response to a voltage-clamp step to ϩ25 mV for 3.0 seconds, followed by a step to -35 mV for 1.0 seconds, as described by Gintant. 35 
I Ks
The slow-activating delayed rectifier current I Ks is present in epicardial, midmyocardial, and endocardial canine ventricular cells. I Ks is modeled as described in Zeng et al, 32 with the exception that the steady-state activation function is fit using a Boltzmann function determined by Liu and Antzelevitch. 33 The voltage-dependent time constant is also shifted by ϩ40 mV in the depolarizing direction to fit the experimental data of Liu and Antzelevitch 33 (see their Figure  13 ). Maximum conductance (G Ks ) is adjusted to yield a tail current density of 0.4 pA/pF in response to 3.0-second-duration voltageclamp steps from the holding potential of -35 to ϩ25 mV, followed by a return to the holding potential 34 (see Figure 5 ). The Ca 2ϩ dependence of I Ks described in the Luo-Rudy phase II guinea pig model is not included, as there are no experimental data constraining this dependence in canine ventricular cells.
I K1
I K1 is fit using data measured at 22°C in isolated canine midmyocardial ventricular myocytes measured by Kääb et al 5 and scaled to 37°C. These data indicate that maximum outward I K1 density is Ϸ2.5 pA/pF at -60 mV 5 (see Reference 5 , Figure 4B ). These data also show that I K1 density is nonnegligible at voltages within the plateau range of the canine action potential. For example, I K1 density is 0.3 pA/pF at 0 mV, a value comparable with the density of I Kr during the plateau phase of the action potential. The functional representation of I K1 in the Luo-Rudy phase II model can therefore not be used, as it approaches 0 at plateau membrane potentials. An alternative formulation better approximating the canine data is presented in the Appendix.
The model of L-type Ca 2ϩ current used is identical to the modeswitching model presented in Jafri et al, 24 with 3 exceptions. First, the voltage dependence of the activation transition rates ␣(V) and ␤(V) and the inactivation variable y(V) are shifted by ϩ10 mV in the depolarizing direction to position the peak L-type Ca 2ϩ current in response to voltage-clamp stimuli at ϩ5 mV, as measured experimentally. 5 Second, the monotonic decreasing steady-state (voltagedependent) inactivation function y ϱ is modified to have an asymptotic value of 0.2 for large positive membrane potentials V. This modification reproduces the slow component of Ca 2ϩ current observed under voltage-clamp stimuli in canine ventricular cells. 5, 37 Finally, peak L-type Ca 2ϩ current density is adjusted to a value of 2.5 pA/pF at a clamp voltage of ϩ5 mV.
J up
In the model of Jafri et al, 24 Ca 2ϩ uptake into network SR (NSR) is modeled using a Hill function with coefficient of 2. Reverse pump rate is assumed to be 0, and Ca 2ϩ leak from NSR to cytoplasm is assumed to be proportional to the gradient of NSR and cytosolic Ca 2ϩ concentrations. Recently, Shannon et al 38 ATPase pump that includes forward-and reverse-current components, each with its own binding constant and peak forward and reverse rates (denoted V maxf and V maxr , respectively). 39 The forward mode exhibits slight cooperativity, whereas the reverse mode is noncooperative. The relative magnitudes of forward-and reverse-current components determine whether SR load increases, is constant, or decreases during diastole. The model is presented in the Appendix.
Failing Canine Ventricular Cell Model
Kääb et al 5 have shown that in the canine tachycardia pacing-induced model of heart failure, I to1 and I K1 are downregulated on average by 66% and 32%, respectively, in terminal heart failure. Only the number of expressed channels is changed; the kinetic properties of I to1 and gating behavior of I K1 are unaltered. On the basis of these data, the effects of terminal heart failure are modeled by reducing the peak conductance of I to1 and I K1 by the factors indicated above. Downregulation of the SR Ca 2ϩ ATPase is modeled by simultaneous scaling of both the forward and reverse maximum pump rates V maxf and V maxr by a scale factor, K SR . Upregulation of the NCX is modeled by increasing a scale factor, K NaCa .
Numerical Methods
The dynamical equations in the Appendix are solved on a Silicon Graphics workstation using the Merson modified Runge-Kutta fourth-order adaptive step algorithm (No. 25, Reference 52), with a maximum step size of 100 microseconds and maximum error tolerance of 10 -6 . The error from all variables is normalized to ensure that each contributes equally to the calculation of global error, as described in Jafri et al. 24 Initial conditions listed in the Appendix are used in all calculations, unless noted otherwise. These initial conditions were computed in response to a periodic pulse train of frequency 1 Hz and were determined immediately before the 11th pulse. Action potentials are initiated using 0.1 AF -1 current injection for 500 microseconds.
The canine ventricular cell model is used to derive quantitative estimates of the NCX scale factor K NaCa and the SR Ca 2ϩ ATPase scale factor K SR from experimental data by fitting model Ca 
Results
Action Potentials and Ca
2؉ Transients: Model Versus Experimental Results Figure 1 demonstrates the ability of the model to reconstruct action potentials and Ca 2ϩ transients of both normal and failing canine midmyocardial ventricular myocytes. The solid and dotted lines in Figure 1A show experimental measurements of normal and failing action potentials, respectively. Model action potentials are shown in Figure  1C . In this figure, the solid line shows a normal action potential. The dashed line shows an action potential when I to1 is reduced by 66% of the normal values and I K1 by 32% of the normal values (the average percentage reductions observed in terminal heart failure.) 5 The dotted line corresponds to these same reductions of I to1 and I K1 , in addition to a 62% reduction of the SR Ca 2ϩ ATPase pump and a 75% increase of the NCX. These values are model-based estimates of the average percentage change in activity of these proteins determined using experimentally derived limits on their function, as described in the following sections.
The model data of Figure 1C show that downregulation of I to1 and I K1 reduces the depth of the phase 1 notch. However, notch depth is larger in the experimental measurements from the failing myocyte ( Figure 1A , dotted line) than is predicted by the model ( Figure 1C , dashed line). This greater notch depth is due to the presence of the Ca 2ϩ -dependent transient outward current I to2 , which is not included in the model. The most significant change in model action potential duration (APD) occurs with upregulation of the NCX and downregulation of the SR Ca 2ϩ ATPase ( Figure 1C , dotted line). These 2 changes alone increase APDs at 90% repolarization (APD 90 ) by Ϸ200 ms. Figure 1D illustrates model normal (solid line) and failing (dotted line) Ca 2ϩ transients. Amplitude of the Ca 2ϩ transient is reduced significantly in the heart failure model. Ca 2ϩ transient shape is flattened, duration is prolonged, and relaxation is slowed. These changes are similar qualitatively to those seen in the experimental data of Figure 1B .
Figures 1E and 1F show L-type Ca 2ϩ and Na ϩ /Ca 2ϩ exchange currents for normal (solid lines) and failing (dotted lines) model cells. The reduction in peak magnitude of the L-type Ca 2ϩ current seen in Figure 1E for the failing model cell results from downregulation of I to1 , which reduces depth of the phase 1 notch and therefore driving force during onset of the L-type Ca 2ϩ current. Figure 1E also shows that L-type Ca 2ϩ current is increased during the later plateau phase of the action potential in failing model cells. The mechanism of this increase will be considered in subsequent sections. Figure 1F shows that Na ϩ /Ca 2ϩ exchange operates in reverse mode, generating a net outward current during most of the plateau phase of the action potential. The magnitude of this outward current decreases during the plateau phase, and in the failing cell model the current becomes significantly smaller than the inward L-type Ca 2ϩ current. These simulations demonstrate the ability of the model to reproduce both normal and failing canine myocyte action potentials and Ca 2ϩ transients. The following sections describe application of the model to estimation of the degree of functional change in the NCX and SR Ca 2ϩ ATPase in control and failing myocytes. The approach is as follows: (1) the time constant of Ca 2ϩ decay ( Ca ) measured with SR function blocked using CPA data is used to estimate the model Na ϩ /Ca 2ϩ exchange scale factor K NaCa ; (2) with K NaCa fixed at this value, the model SR Ca 2ϩ ATPase scale factor K SR required to reproduce the Ca measured in physiological solutions is determined; (3) the SR Ca 2ϩ ATPase reduction in heart failure is cross-checked independently by determining the model SR Ca 2ϩ ATPase scale factor required to reproduce the Ca measured under Na ϩ -free conditions (0-Na data) with the model Na ϩ /Ca 2ϩ exchange set to 0; and (4) the model Na ϩ /Ca 2ϩ exchange scale factor is estimated independently from Ca in physiological solutions using the estimate of SR function determined in step 3. ATPase pump rates V maxf and V maxr given in Table 4 of the Appendix have been selected to yield a similar time constant when K SR ϭ1.0. Measured variation about this value is accounted for by K SR values in the interval (0.85, 1.15).
The experimental value of Ca measured in failing myocytes using physiological solutions is 292Ϯ23 ms. Dependence of model Ca on K SR when K NaCa is fixed at the value estimated for failing canine myocytes (0.53) is shown by the curve labeled with open squares in Figure 2B . K SR ϭ0.38 yields a model Ca equal to that observed experimentally. The experimental deviation of Ca is accounted for by K SR values in the interval (0.26, 0.51). Assuming the average value of K SR in normal cells to be 1.0, these data suggest a functional downregulation of the SR Ca 2ϩ ATPase pump in heart failure in the range of 49% to 74%, with average value 62%.
Estimation of NCX and SR Ca 2؉ ATPase Activity in Normal and Failing Myocytes: 0-Na Experiments
To provide a second, independent measure of altered Ca 2ϩ handling protein expression in heart failure, O'Rourke et al 23 decay rates match those measured experimentally using physiological solutions. This procedure can be applied to data obtained from both normal and failing cells to assess the extent of functional upregulation and downregulation of the NCX and SR Ca 2ϩ ATPase in heart failure. To mimic 0-Na conditions, K NaCa was set equal to 0. K SR was then varied, and the time constant for Ca 2ϩ reuptake into SR was computed. Model Ca values are plotted as a function of K SR in Figure 2B ( Figure 2A . K NaCa ϭ0.22 yields a model Ca equal to that observed experimentally using physiological solutions (219Ϯ36 ms). Experimental deviation of Ca is accounted for by K NaCa values in the interval (0.13, 0.43). Dependence of model Ca on K NaCa when K SR is fixed at the value estimated for failing canine myocytes under 0-Na conditions (0.51) is shown by the curve labeled with open squares in Figure 2A . K NaCa ϭ0.35 yields a model Ca equal to the average value observed experimentally using physiological solutions (292Ϯ23 ms). Experimental deviation of Ca is accounted for by K NaCa values in the interval (0.26, 0.46). Assuming the normal value of K NaCa to be 0.22, these data suggest a functional upregulation of the NCX in heart failure in the range of 18% to 109%, with average value 38%. This estimate of altered expression of NCX in heart failure has greater variability than that obtained previously using the CPA data but is consistent in that it also indicates increased expression.
Parametric Dependence of Voltage-Clamp Ca
2؉
Transients on SR Ca 2؉ ATPase and NCX Levels
The above analyses provide estimates of K SR and K NaCa in normal and failing myocytes. Results indicate functional downregulation of the SR Ca 2ϩ ATPase pump and upregulation of the NCX in heart failure. The parametric dependence of model cytosolic Ca 2ϩ transients on K SR and K NaCa is examined next.
Model cytosolic Ca 2ϩ concentration (ordinate, mol/L) versus time (abscissa, seconds) is shown in Figure 3A as K SR is varied. In these simulations, K NaCa is constant at the value estimated using CPA data from normal cells (K NaCa ϭ0.30). K SR is varied from 1.0 to 0.0 in steps of 0.1. Ca 2ϩ transients are in response to a 1-Hz voltage-clamp stimulus (holding potential -97 mV, step potential 3 mV, and duration 200 ms).
Response to the final stimulus of 10 stimulus cycles is shown, with the time origin translated to 0 seconds. These data show that reduction of the model SR Ca 2ϩ ATPase pump, simulating the effects of downregulation of this pump in heart failure, reduces the amplitude of the early peak of the Ca 2ϩ transient (marked by the arrow). This early peak disappears as K SR approaches 0. Figure 3B shows JSR Ca 2ϩ levels for each of the responses in Figure 3A . Reduction of the early peak in the data of Figure 3A coincides with decreasing K SR values, as shown in the data of Figure  3A , as well as Figure 2B (open circles). Figure 4A shows model cytosolic Ca 2ϩ concentration (ordinate, mol/L) versus time (abscissa, seconds) as K NaCa is varied in steps of 0.5 from 0.5 to 2.5. A plot for K NaCa ϭ0.25 is also shown. K SR is constant at the value estimated using CPA data from normal myocytes (K SR ϭ1.0). Voltage clamp steps from -97 mV to ϩ3 mV with 200 ms duration are applied at a rate of 1.0 Hz. The final Ca 2ϩ transient in a sequence of 10 is displayed, with the time origin translated to 0 seconds. There are 3 effects of increased K NaCa . These are (1) increased rate of Ca 2ϩ extrusion and lower diastolic Ca 2ϩ at the holding potential, (2) reduction in Ca 2ϩ transient amplitude in response to the ϩ3 mV voltage-clamp step, and (3) "flattening" of the Ca 2ϩ transient during the voltage-clamp step. The increased Ca 2ϩ extrusion at the holding potential is a direct consequence of increased NCX activity when the exchanger is operating in the forward mode at the -97-mV holding potential, as shown in Figure 4B . This figure also shows that the NCX operates in reverse mode at the ϩ3 mV clamp potential, thus generating Ca 2ϩ influx. Figure 4B . Decreased K NaCa values also produce smaller Ca 2ϩ transient decay rates, as seen by the data of Figure 4A , as well as Figure 2A (open circles). Figure 5A shows model Ca 2ϩ transients in response to a 1-Hz voltage-clamp pulse train. These transients were computed using K SR and K NaCa parameter values determined from the experimental series in the presence and absence of CPA. The solid line is the normal model Ca 2ϩ transient (K NaCa ϭ0.30 and K SR ϭ1.0). The peak Ca 2ϩ level (480 nmol/L) agrees well with the value measured experimentally in normal myocytes (450Ϯ75 nmol/L). 23 23 Figure 5B shows a Ca 2ϩ transient measured experimentally. The amplitude and waveform of the model predictions in Figure 5A are in close agreement with these experimental data. Figure 5C shows a plot of the L-type Ca 2ϩ current during the Ca 2ϩ transients of Figure 5A . The parameter changes have relatively little effect on peak current, but increases in K NaCa or decreases in K SR produce a monotonic increase in the late component of the L-type Ca 2ϩ current. As shown in Figure  5D , these same parameter changes also produce monotonic decreases of the subspace Ca 2ϩ transient peak. Thus, the increase in the late component of L-type Ca 2ϩ current seen in Figure 5C results from a decrease in Ca 2ϩ -mediated inactivation of this current due to reductions in magnitude of the subspace Ca 2ϩ transient, which is in turn a consequence of reduced SR Ca 2ϩ load. As can be appreciated by examining the magnitude of the change in L-type Ca 2ϩ current density with alterations in Ca 2ϩ handling, this late component of the L-type Ca 2ϩ current would be expected to play an important role in determining the action potential plateau. This suggests that in heart failure, alterations in the expression of Ca Only response to the final stimulus is shown. A family of responses is shown in which K NaCa is varied from 0.5 to 2.5 in steps of 0.5 (response for K NaCa ϭ0.25 is also shown), while K SR is held constant at the value accounting for the Ca 2ϩ relaxation rate measured in normal myocytes under 0-Na conditions. B, Model NaCa exchange current I NaCa as a function of time in response to the stimuli described in Figure 3A .
Ca
2؉ Transients in Response to Voltage-Clamp Stimuli: Model Versus Experimental Results
Discussion
In this article, we present a model of the canine midmyocardial action potential and Ca 2ϩ transient. The model is used to estimate the magnitude of SR Ca 2ϩ ATPase pump rates and NCX current in normal and failing myocytes 23 using 2 methods. In the first method, model SR Ca 2ϩ ATPase current is set to 0, and the NCX current is scaled to yield Ca 2ϩ relaxation time constants in response to voltage-clamp stimuli matching those measured experimentally in normal and failing myocytes in the presence of CPA, a blocker of the SR Ca 2ϩ ATPase. The extent of functional upregulation of the NCX in heart failure estimated using this approach is in the range of 60% to 100%, with average value 75%. Having constrained the model NCX current, model SR Ca 2ϩ ATPase pump current is then estimated by matching the model Ca 2ϩ relaxation rate to experimental data obtained in the absence of CPA. Comparison of model SR Ca 2ϩ ATPase pump currents estimated for normal and failing myocytes suggests a functional downregulation in heart failure in the range of 49% to 74%, with average value 62%.
In the second method, model NCX current is set to 0, and the SR Ca 2ϩ ATPase current is scaled to yield Ca 2ϩ relaxation time constants matching those measured experimentally under 0-Na conditions. Functional downregulation of the SR Ca 2ϩ ATPase current in heart failure estimated using this approach is in the range of 41% to 54%, with average value 49%. Having constrained the model SR Ca 2ϩ ATPase current, NCX current is estimated by matching the model Ca 2ϩ relaxation rate to experimental data obtained in control intracellular and extracellular sodium concentrations. Functional NCX upregulation in heart failure estimated using this approach is in the range of 18% to 109%, with average value 38%.
Analysis of protein levels in canine hearts subjected to the tachycardia pacing protocol reveal that both SR Ca 2ϩ ATPase and phospholamban proteins are reduced on average by 28% 23 and that NCX protein is increased on average by 104%. 23 Both steady-state mRNA and expressed levels of E-C coupling proteins in failing human ventricular cells have been measured. The majority of reports agree that there is a Ϸ50% reduction of: (1) 12, 17, 18 and (3) direct SR Ca 2ϩ ATPase uptake rate during heart failure. 19 There is a 55% to 79% increase in Na-Ca exchanger mRNA levels, 12,20 a 36% to 160% increase in expressed protein levels, 12,20 -22 and an approximate factor of 2 increase in Na ϩ /Ca 2ϩ exchange activity in human heart failure. 22 The model-based estimates of functional upregulation and downregulation of the NCX and SR Ca 2ϩ ATPase pump reported here are consistent with these reports. Model estimates of average SR Ca 2ϩ ATPase functional downregulation are 49% and 62%, depending on the estimation methods used. These values agree well with estimates of mRNA level, protein level, and SR Ca 2ϩ ATPase uptake rate measured in human heart failure, but suggest a slightly larger degree of downregulation than indicated by measurements of protein level in canine tachycardia pacing-induced heart failure 23 (28%). Model estimates of average NCX upregulation are 38% and 75%. These estimates agree well with measured increases in mRNA levels in human heart failure and are within the range of variability of measured NCX protein levels in human heart failure. However, the model estimates are slightly lower than is suggested by the increased protein levels measured in the failing canine heart. 23 Ca 2ϩ transients measured in failing human and canine ventricular myocytes exhibit reduced amplitude and slowed relaxation. 5,40 -43 Model simulations of Ca 2ϩ transients in response to voltage-clamp stimuli reported here demonstrate that the altered expression of the NCX and SR Ca 2ϩ ATPase pump measured in failing canine myocytes is sufficient to account for these properties. Both changes contribute to reduced SR Ca 2ϩ load and release and therefore reduced amplitude of the early Ca 2ϩ transient peak ( Figures 3A and  4A) . The shape of the Ca 2ϩ transient is also controlled by both NCX and SR Ca 2ϩ ATPase levels. As the Ca 2ϩ ATPase pump is downregulated (Figure 3A) , the shape of the plateau portion of the voltage-clamp Ca 2ϩ transient changes from negative to 0, then to positive slope. This change in slope is produced by a decrease in early Ca 2ϩ release from JSR, which in turn increases the dependence of Ca 2ϩ transient shape on Ca 2ϩ entry through the L-type Ca 2ϩ channel. Upregulation of NCX also influences Ca 2ϩ transient shape, tending to flatten the Ca 2ϩ transient plateau by increasing reverse-mode Ca 2ϩ entry at depolarized potentials ( Figure 4A ). The interplay between both of these factors accounts for the flattened Ca 2ϩ transient shape seen in failing myocytes (Figure 1D , model; Figure 1B , experimental data). Model Ca 2ϩ transients in response to voltage-clamp stimuli exhibit a "knob" at the early peak of the transient (see Figure  3A , for example) that does not appear to be present in the experimental data. This knob disappears as the SR Ca 2ϩ level becomes small ( Figure 3A) , indicating that the knob is dependent on SR Ca 2ϩ release. The knob is likely an artifact of model construction. All SR Ca 2ϩ release in this model occurs from a single functional unit, defined as a set of L-type Ca 2ϩ channels, RyR channels, and the subspace within which they interact. Stern has referred to such models as common pool models. 44 The knob reflects a large, single Ca 2ϩ release event from this single functional unit. In contrast, real cardiac cells have a large number of functional units in which there is local control of calcium-induced calcium release. We have recently implemented a local control model of Ca 2ϩ release consisting of an ensemble of functional units, in which each functional unit is defined as an L-type Ca 2ϩ channel interacting with a small set of RyR channels through a diadic space. Both L-type Ca 2ϩ channels and RyR channels are modeled stochastically using the channel models presented in Jafri et al. 24 In such a model, the stochastic nature of RyR channel openings produces a variable latency of Ca 2ϩ release in each functional unit. The Ca 2ϩ transients computed using this model exhibit the property of gradedness and do not exhibit the knob seen in Figure 3A due to temporal smearing of Ca 2ϩ release times.
A recent study has put forth the hypothesis that coupling between L-type Ca 2ϩ channels and RyR channels may be altered in heart failure and that this altered coupling leads to a reduction in amplitude of the Ca 2ϩ transient. 45 The results presented here cannot refute this hypothesis. Indeed, structurally detailed models of RyR channel and L-type Ca 2ϩ channel interactions in the diadic space predict a strong dependence of these interactions on geometric factors. 46 -48 However, the results reported here indicate that such an assumption is not necessary to account for reduced amplitude of Ca 2ϩ transients in failing myocytes. Rather, these simulations indicate that the altered expression of Ca 2ϩ handling proteins reported by several different groups in both failing human and canine myocytes could account for changes in Ca 2ϩ transient amplitude and shape. The data of Figure 1 demonstrate that downregulation of the outward repolarizing currents I K1 and I to1 , together with altered expression of the NCX and SR Ca 2ϩ ATPase pump, can account for differences in both action potential and Ca 2ϩ transient shape in heart failure. However, the data of Figure  1C also indicate that downregulation of I K1 and I to1 , at least to the extent measured on average in failing cells, has a small effect on APD. Instead, altered expression of Ca 2ϩ handling proteins plays a significant role in APD prolongation.
It is not surprising that downregulation of model I K1 has only a modest impact on APD, as I K1 is primarily responsible for the terminal phase of repolarization. However, the finding that reduction of model I to1 has only a small effect on APD differs from the experimental results of Kääb et al 5 in dog myocytes and of Beuckelmann et al 9 in human cells. These experiments were performed using EGTA as an intracellular Ca 2ϩ buffer. This buffering minimizes the modulatory effects of Ca 2ϩ and thus enhances the relative influence of outward K currents on action potential characteristics. When effects of EGTA buffering are simulated in the model described in this article, block of I to1 has a greater influence on APD. An example is shown in Figure 6 . The Ca 2ϩ buffering effects of EGTA were modeled using the fast buffering approximation developed by Wagner and Keizer, 49 with EGTAϭ 10 mmol/L and the dissociation constant K m ϭ0.15 mol/L. Block of I to1 by 95% increases APD 90 by 73 ms, or Ϸ25% of the control value. These results again emphasize the important modula-tory role of Ca 2ϩ on action potential characteristics in the canine myocyte.
It is also possible that 4-AP block of K currents other than I to1 occurred in the Kääb et al 5 experiments, but that such effects were not resolvable. Steady-state current-voltage relations were measured in the presence and absence of 4-AP to assess whether or not this was the case. Data are shown in Figure 10C of Kääb et al 5 and indicate that experimental variability in steady-state current at 0 mV (a potential near that of the action potential plateau) is roughly Ϯ1.0 pA/pF. The sum of model outward currents I to1 , I K1 , I Kr , and I Ks during the plateau is comparable with the magnitude of this variability in the experimental measurements (Ϸ1.0 pA/pF). Genetic approaches for selective suppression of I to1 50,51 may turn out to be more useful than pharmacological approaches in determining the influence of this current on APD.
The model predicts that one important mechanism of APD prolongation in heart failure is that shown in Figures 1 and 5 . Under conditions of reduced SR Ca 2ϩ release, there is less Ca 2ϩ -mediated inactivation of the L-type Ca 2ϩ current. The resulting increase of inward current, as shown for voltageclamp stimuli in Figure 5C and for action potentials in Figure  1E , helps to maintain and prolong the plateau phase of the action potential. Investigation into the relative contribution of the various Ca 2ϩ -regulatory mechanisms and Ca 2ϩ -dependent membrane currents in determining the action potential shape and duration is an important area for future experimental and modeling studies.
Appendix
Standard Units (Unless Otherwise Noted) Used in the Following Set of Equations
Quantity Units
Membrane potential mV
Membrane current AF
Ϫ1
Membrane conductance mSF
Ionic flux mMms
Ϫ1
Concentration mM
Time constant ms
Rate constant ms
Ϫ1
Membrane Currents
␤ m ϭ0.08e ϪV 11 For VՆϪ40 mV, 
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